Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2023
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2023 (H.R. 2639) is a health policy bill introduced in the House during the 118th Congress. The bill aims to address issues related to patient protection and fraud in the field of electrodiagnostic medicine. As of the latest update, the bill has been referred to the Subcommittee on Health but has failed or expired without further legislative action. No official summary or full text is available to provide detailed provisions or mechanisms of the bill.
H.R. 2639 sought to improve patient protections and reduce fraud in electrodiagnostic medicine but did not advance beyond subcommittee referral and ultimately expired.
- The bill focuses on patient protection and fraud elimination specifically within electrodiagnostic medicine.
- It was introduced in the House of Representatives during the 118th Congress.
- The bill was referred to the Subcommittee on Health but did not progress further and is now classified as failed or expired.
['Patients receiving electrodiagnostic medical services', 'Healthcare providers adhering to fraud prevention standards', 'Health insurance programs and payers aiming to reduce fraudulent claims']
['Lack of available full bill text limits understanding of specific enforcement or oversight mechanisms.', 'Potential costs or administrative burdens associated with implementing fraud prevention measures are unknown.', 'Unclear authority or regulatory changes proposed due to absence of detailed provisions.']
The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health. It did not advance beyond this stage and is recorded as failed or expired. No further legislative actions or debates are documented.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential reduction in fraudulent billing practices in electrodiagnostic medicine if implemented.', 'Possible increased administrative oversight or compliance requirements for healthcare providers.', 'Improved patient trust in electrodiagnostic services through enhanced protections.']
Due to the absence of the bill's full text and official summary, transparency is limited. This restricts the ability to fully assess the scope, enforcement mechanisms, and fiscal impacts of the bill. Monitoring future reintroductions or related legislation is advisable for comprehensive oversight.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.